Loma Linda University

Enrollment Information
Call us at: 909-558-1000

Faculty Directory
  
Carlos Garberoglio, MD
Chair, Surgery
School of Medicine
Head, Surgery, Surgical Oncology Division
School of Medicine
Professor, Surgery
School of Medicine
Professor, Basic Sciences
School of Medicine
Publications    Book Review - Scholarly Journals--Published
  • Garberoglio, C.A.; Cordon-Cardo, C.; Sorvillo, J.; Mendelson, J.; and Brennan, M. “Expression of epidermal growth facto receptor (EGFr), alpha transforming growth factor (TGF), and epidermal growth factor molecule (EGFm) in normal tissue and in high grade myosarcomas.” Proceedings of the American Association for Cancer Research 31:52, 1990. ( 0/1990 )
  Scholarly Journals--Published
  • The Promotion of Laparoscopic Suturing Competence among Residents. Baerg J, Michelotti M, Garberoglio C, Reeves M. Am Surg. 2012 Sep;78(9):1012-4. No abstract available. ( 9/2012 )
  • Outcomes in the Management of Appendicitis and Cholecystitis in the Setting of a New Acute Care Surgery Service Model: Impact on Timing and Cost. Cubas RF, Gomez NR, Rodriguez S, Wanis M, Sivanandam A, Garberoglio CA. J Am Coll Surg. 2012 Aug 2. [Epub ahead of print] ( 8/2012 )
  • Richard L. White Jr.  Gregory D. Ayers, Virginia H. Stell, Shouluan Ding, Jeffrey E. Gershenwald, Jonathan C. Salo, Barbara A. Pockaj, Richard Essner, Mark Faries, Kim James Charney, Eli Avisar, Axel Hauschild, Friederike Egberts, Bruce J. Averbook, Carlos A. Garberoglio, John T. Vetto, Merrick I. Ross, David Chu, Vijay Trisal, Harald Hoekstra, Eric Whitman, Harold J. Wanebo, Daniel DeBonis, Michael Vezeridis, Aaron Chevinsky, Mohammed Kashani-Sabet, Yu Shyr, Lynne Berry, Zhiguo Zhao, Seng-jaw Soong, Stanley P. L. Leong and for the Sentinel Lymph Node Working Group “Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database.”  Ann Surg Oncol. 2011 Dec;18(13):3593-600. Epub 2 ( 12/2011 )
  • Lew MW, Kravits K, Garberoglio C, Williams AC. "Use of preoperative hypnosis to reduce postoperative pain and anesthesia-related side effect." Int J Clin Exp Hypn. 2011 Oct-Dec;59(4):406-23. ( 10/2011 - 12/2011 )
  • Noronha Y, Raza A, Hutchins B, Chase D, Garberoglio C, Chu P, Weiss L, Wang J. “CD34, CD117, and Ki-67 Expression in Phyllodes Tumor of the Breast: An Immunohistochemical Study of 33 Cases.” Int J Surg Pathol. 2011 Apr;19(2):152-8. Epub 2010 Nov 17. ( 4/2011 )
  • Betancourt H, Flynn PM, Riggs M, Garberoglio C. “A cultural research approach to instrument development: the case of breast and cervical cancer screening among Latino and Anglo women.” Health Educ Res. 2010 Dec;25(6):991-1007. Epub 2010 Sep 23. ( 12/2010 )
  • Wang J, Saukel GW, Garberoglio CA, Srikureja W, Hsueh CT. "Pathological complete response after neoadjuvant chemotherapy with trastuzumab-containing regimen in gastric cancer: a case report." J Hematol Oncol. 2010 Sep 9;3(1):31. ( 9/2010 )
  • Pal SK, Lau SK, Kruper L, Nwoye U, Garberoglio C, Gupta RK, Paz B, Vora L, Guzman E, Artinyan A, Somlo G."Papillary carcinoma of the breast: an overview." Breast Cancer Res Treat. 2010 Aug;122(3):637-45. Epub 2010 Jun 4. ( 8/2010 )
  • Malik I, Hussein F, Bush D, Alqaisi M, Bernal P, Byrd J, Garberoglio C. "A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer." Am J Clin Oncol. 2010 Jun;33(3):242-5. ( 6/2010 )
  • S. Kalla Singh, QW Tan, C. Brito, M. DeLeon, D. DeLeon, C. Garberoglio. “Differential insulin-like growth factor II (IGF-II) expression: A potential role for 3 breast cancer survival disparity.” Growth Hormone & IGF Research, 2010 Apr;20(2):162-170. Epub 2010 Jan 25. ( 1/2010 )
  • Maximilian Diehn, Robert W. Cho, Neethan A. Lobo, Tomer Kalisky, Mary Jo Dorie, Angela N. Kulp, Dalong Qian, Jessica S. Lam, Laurie E. Ailles, Manzhi Wong, Benzion Joshua, Michael J. Kaplan, Irene Wapnir, Frederick M. Dirbas, George Somlo, Carlos Garberoglio, Benjamin Paz, Jeannie Shen, Sean K. Lau, Stephen R. Quake, J. Martin Brown, Irving L. Weissman, Michael F. Clarke. Association of reactive oxygen species levels and radioresisitance in cancer stem cells. Nature Journal, 2009 April; 458:780-783. ( 4/2009 )
  • Bush, D.; Slater, J.D.; Hocko, J.; Yuh, G.; Garberoglio, C.; Slater, J.M. “A technique of partial breast irradiation utilizing proton beam radiotherapy. Comparison with Conformal x-ray therapy.” Cancer J. 2007 Mar-Apr;13 (2):114-8. ( 3/2007 - 4/2007 )
  • Leong, S.;Accortt, N.; Essner, R.; Ross, M.; Gershenwald, J.; Pockaj, B.; Joekstra, H.; Garberoglio, C.; White, R.; Chu, D.; Biel, M.; Charney, K., Wanebo, H.; Avisar, E.; Vetto, J.; Soong, S.; for the Sentinel Lymph Node Working Group. Arch Otolaryngol Head Neck Surg. 2006;132:370-373. ( 0/2006 )
  • Weik, Lum, Esquivel, Tully, Bae, Petersen, Jaque, Reeves, Garberoglio, C. “The Gail Model predicts breast cancer in women with suspicious radiographic lesions.” The American Journal of Surgery 2005; 190: 526-9. ( 0/2005 )
  • Komorowska-Timek, E.; Gabriel, A.; Bennett, D.; Miles, D.; Garbergolio, C, Cheng, C.; Gupta, S. “Artificial Dermis as an Alternative for Coverage of Complex Scalp Defects following Excision of Malignant Tumors.” Plast. Reconstr. Surg. 2005 (115): 1010. ( 0/2005 )
  • Oberg, K; Wells, K; Serag, I; Garberoglio, C.; Akin, M. “ACTH-Secreting Islet Cell Tumor of the Pancreas Presenting as Bilateral Ovarian Tumors and Cushing’s Syndrome.” International Journal of Gynecological Pathology  2002 Jul;21(3):276-80. ( 7/2002 )
  • Robles, A.; Bianchi, C.; Garberoglio, C.; and Tabuenca, A. “Intraoperative cholangiogram as a predictor of PO ERCP.” Hepatology 24(4):484A, #1431, October 1997. ( 10/1997 )
  • Robles, A.; Owens, C.; Bianchi, C.; Pitombo, C.; Garberoglio, C.; and Tabuenca, A. “Outpatient Laparoscopic cholecystectomy is safe for the obese and morbidly obese patient.” Surgical Endoscopy 10(2):224, February 1996. ( 2/1996 )
  • Robles, A.; Owens, C.; Bianchi, C.; Walter, M.; Pitombo, C.; Garberoglio, C.; Tabuenca, A. “A prospective comparison of the manometric effect of division or non-division of the short gastric vessels in Nissenfundoplication – Preliminary report.” Surgical Endoscopy 2:224, February 1996. ( 2/1996 )
  • Robles, A.; Owens, C.; Bianchi, C.; Pitombo, C.; Garberoglio, C.; and Tabuenca, A. “Outpatient Laparoscopic cholecystectomy – Outcome by ASA grading.” Surgical Endoscopy 10(2):252, February 1996. ( 2/1996 )
  • Tan, H.P.; and Garberoglio, C. ”Pancreatic Adenocarcinoma: an update.” The Journal of the American College of Surgeons 183:164-184, 1996. ( 0/1996 )
  • Bowman, R.; Kanacki, Z.; Garberoglio, C.; and Chase, D. “Comparison between image cytometry and flow cytometry: a priori factors which influence technique.” Analytical and Quantitative Cytology and Histology 17:4, 1995. ( 0/1995 )
  • Chang, A.C.; Balasubramaniam, K.; Garberoglio, C.; and Chen, Y. “Early cancer of tail of the pancreas presenting as acute idiopathic pancreatitis.” Hospital Physician 31(7):23-27, 1995. ( 0/1995 )
  • Robles, A.; Andrews, H.; and Garberoglio, C. “Laparoscopic splenectomy: Present status and future outlook.” International Surgery 79:332-334, 1994. ( 0/1994 )
  • Wongworawat, M.D.; Aitken, D.; Robles, A.; and Garberoglio, C. “The impact of prior intra-abdominal surgery on Laparoscopic cholecystectomy.” American Surgeon 60:763-766, 1994. ( 0/1994 )
  • Tabuenca, A.; Smith, J.; Ihde, J.; Aittken, D.; and Garberoglio, C. “Factors influencing survival in advanced gastric cancer.” The American Surgeon 59:(12)855-858, December 1993. ( 12/1993 )
  • Garberoglio, C.A.; Dudas, M.; Casper, E.; Bertino, J.; and Cordon-Cardo, C. “Expression of P-glycoprotein in normal muscle cells and myogenic tumors.” Arch of Pathology and Laboratory Medicine 116:1055-1061, October 1992. ( 10/1992 )
  • Garberoglio, C.A.; Cordon-Cardo, C.; Sorvillo, J.; Casper, E.; Houghton, A.N.; Mendelsohn, J; and Brennan, M.E. “Expression of epidermal growth factor receptor and transforming growth factor alpha in human myosarcomas.” Journal of Experimental and Clinical Cancer Research 11:2, 1992. ( 0/1992 )
  • Tan, H.P.; Nehlsen-Cannarella, S.L.; Garberoglio, C.A.; and Tosk, J.M. “Recombinant Interleukin-4 enhances the chemiluminescent oxidative burst of murine peritoneal macrophages.” Journal of Leukocyte Biology 49:587-591, 1991. ( 0/1991 )
  • Tan, H.P.; Garberoglio, C.A.; and Nehlsen-Cannarella, S.L. “14M1.4 Bone marrow-derived macrophages as a model for IL-4-activated macrophages as measured by chemiluminescent oxidative burst.” Federation of American Societies for Experimental Biology 1991. ( 0/1991 )
  • Tan, H.P.; Garberoglio, C.A.; Lau, B.H.S.; and Nehlsen-Cannarella, S.L. “Further evidence of murine recombinant IL-4 species specifity as measured by chemiluminescent oxidative bust in macrophages.” Proceedings of the American Association for Cancer Research 32:234 (1388), 1991 ( 0/1991 )
  • Garberoglio, C.A.; Cordon-Cardo, C.; and Brennan, M. “Expression of P-glycoprotein (P-gp) in normal muscle cells and in high-grade myogenic ttumors (HGMT).” Proceedings of the American Society of Clinical Oncology 9:(1225) 316, 1990. ( 0/1990 )
  • Garberoglio, C.A.; Cordon-Cardo, C.; and Brennan, M. “Expression of P-glycoprotein (P-gp) in normal muscle cells and in high-grade myogenic ttumors (HGMT).” Proceedings of the American Society of Clinical Oncology 9:(1225) 316, 1990. ( 0/1990 )
  • Henarejos, A.L.; Altorki, N.; Garberoglio, C.A.; and Moossa, A.R. “The interaction of somatostatin and prostaglandin E2 on pancreatic function.” Surgical Gastroenterology 2:139-141, 1985. ( 0/1985 )
  • Ipp, E.; Garberoglio, C.A.; Richter, H.M. III; Moossa, A.R.; and Rubenstein, A.H. “Naloxone decreases centrally induced hyperglycemia: Evidence for an opioid role in glucose homeostasis.” Diabetes 33:619-621, 1984. ( 0/1984 )
  • Billiar, T.R.; Garberoglio, C.A.; and Schraut, W.H. “Maltose absorption as an indicator of small-intestinal allograft rejection.” Journal of Surgical Research 37:75-82, 1984. ( 0/1984 )
  • Garberoglio, C.A.; Richter, H.M. III; Henarejos, A.L.; Moossa, A.R.; and Baker, A.L. “Pharmacological and physiological doses of insulin and determinants of bile flow in dogs.” American Journal of Physiology 245:G157-G163, 1983. ( 0/1983 )
  • Bickerstaff, K.I.; Garberoglio, C.A.; Baker, A.L.; and Moossa, A.R. “Hormonal control of biliary lipid secretion in dogs.” Annals of Surgery 198 No. 2:168-171, 1983. ( 0/1983 )
  • Garberoglio, C.A.; Wernly, J.A., Henerajos, A.; Baker, A.L.; and Moossa, A.R. “The effect of different glucose concentrations in portal circulation on bile secretion.” Rev. Argent. Cir. 44 No. 3-4:119-121, 1983. ( 0/1983 )
  • Schraut, W.H.; Rosemurgy, A.R.; and Garberoglio, C.A. “Small bowel transplantation: Effect of portal versus systemic venous drainage of the allograft.” European Surgical Research 14, S1:95, 1983. ( 0/1983 )
  • Bickerstaff, K.I.; Garberoglio, C.A.; Baker, A.L.; and Moossa, A.R. “Effect of physiological doses of insulin and glucagon on biliary lipid secretion.” Surgical Forum 33:204-206, 1982. ( 0/1982 )
  • Garberoglio, C.A.; Bickerstaff, K.I.; Baker, A.L.; and Moossa, A.R. “Is glucagon a Choleretic hormone at physiologic blood levels?” American Journal of Surgery 143: 61-66, 1982. ( 0/1982 )
  • Ipp, E.; Piran, V.; Richter, H.M. III; Garberoglio, C.A.; Moossa, A. R.; and Rubenstein, A.H. “Central Control of peripheral circulating somatostatin in dogs: Effect of 2-deoxyglucose.” American Journal of Physiology 243:E213-E216, 1982. ( 0/1982 )
  • Holmes, S.J.K.; Richter, H.M. III; Garberoglio, C.A.; Block, G.E.; and Moossa, A.R. “The Surgical treatment of Crohn’s disease.” British Journal of Clinical Practice 35:5-12, 1981. ( 0/1981 )
  • Ipp, E.; Richter, H.M. III; Garberoglio, C.A.; Moossa, A.R.; and Rubenstein, A. “Central Control of circulating plasma somatostatin: Effect of intracerebroventricular 2-deoxyglucose.” Diabetologia 21(3):285, 1981. ( 0/1981 )
  • Garberoglio, C.A.; Richter, H.M. III; Baker, A.L.; and Moossa, A.R. “Insulin induced choleresis during somatostatin infusion.” Surgical Forum 31:196, 1980. ( 0/1980 )
  • Tabuenca, A.; Mohan, S.; Garberoglio, C.; Borgen, P.; Rolos, T.; and Linkhart,     T. “Parathyroid hormone related protein is not the primary osteolytic factor produced by breast tumor cells in vitro.” World Journal of Surgery 19(1):1-6. (*)
  Scholarly Journals--Accepted
  • Bush DA, Slater JD, Garberoglio C, Do S, Lum S, Slater JM. “ Partial Breast Irridiation Delivered with Proton Beam: Results of a Phase II Trial. Clinical Breast Cancer 2011 Aug;11(4):241-5 ( 8/2011 )
  Non-Scholarly Journals
  • DeLeon, D.; Martinez, C.; Kanaki, Z.; Bianchi, C.; and Garberoglio, C. “Prognostic factors in breast cancer – What is new?” The Bulletin Journal of San Bernardino Medical Society, September 21-26, 1995. ( 9/1995 )
  • Garberoglio, C.A.; and Kinne, D. “The role of axillary lymphadenectomy in clinical Stage I and II breast cancer.” Current Topics in Surgical Oncology, ed. Fegiz, G.F., et al. Milano: Masson. 573-584, October 1991. ( 10/1991 )
  • Vitelli, C.; Garberoglio, C.A.; and Sigurdson, E. “Isolated hyperthermic liver perfusion for unresectable hepatic metastases. Rationale, indications and preliminary results.” Current Topics in Surgical Oncology, ed. Fegiz, G.F., et al. Milano: Masson. 393-401, October 1991. ( 10/1991 )